Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

1.
2.

Gaucher's disease type I: a disease masked by the presence of abnormal laboratory tests common to primary liver disease.

Saadi T, Rosenbaum H, Veitsman E, Baruch Y.

Eur J Gastroenterol Hepatol. 2010 Aug;22(8):1019-21. doi: 10.1097/MEG.0b013e3283369f09.

PMID:
20093936
[PubMed - indexed for MEDLINE]
3.

The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.

Piran S, Roberts A, Patterson MA, Amato D.

Blood Cells Mol Dis. 2009 Nov-Dec;43(3):289-93. doi: 10.1016/j.bcmd.2009.08.002. Epub 2009 Sep 30.

PMID:
19793665
[PubMed - indexed for MEDLINE]
4.

Living with Gaucher disease: Emotional health, psychosocial needs and concerns of individuals with Gaucher disease.

Packman W, Crosbie TW, Behnken M, Eudy K, Packman S.

Am J Med Genet A. 2010 Aug;152A(8):2002-10. doi: 10.1002/ajmg.a.33527.

PMID:
20635362
[PubMed - indexed for MEDLINE]
5.

Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.

Pastores GM, Elstein D, Hrebícek M, Zimran A.

Clin Ther. 2007 Aug;29(8):1645-54.

PMID:
17919546
[PubMed - indexed for MEDLINE]
6.

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A.

Arch Intern Med. 2000 Oct 9;160(18):2835-43.

PMID:
11025794
[PubMed - indexed for MEDLINE]
7.

Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.

Mistry PK, Sirrs S, Chan A, Pritzker MR, Duffy TP, Grace ME, Meeker DP, Goldman ME.

Mol Genet Metab. 2002 Sep-Oct;77(1-2):91-8.

PMID:
12359135
[PubMed - indexed for MEDLINE]
8.

[Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].

Tóth J, Szücs FZ, Benkö K, Maródi L.

Orv Hetil. 2003 Apr 20;144(16):749-55. Hungarian.

PMID:
12778625
[PubMed - indexed for MEDLINE]
9.

The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause).

Zimran A, Morris E, Mengel E, Kaplan P, Belmatoug N, Hughes DA, Malinova V, Heitner R, Sobreira E, Mrsić M, Granovsky-Grisaru S, Amato D, vom Dahl S.

Blood Cells Mol Dis. 2009 Nov-Dec;43(3):264-88. doi: 10.1016/j.bcmd.2009.04.003. Epub 2009 Jun 6. Review.

PMID:
19502088
[PubMed - indexed for MEDLINE]
10.

The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.

Kaplan P, Andersson HC, Kacena KA, Yee JD.

Arch Pediatr Adolesc Med. 2006 Jun;160(6):603-8.

PMID:
16754822
[PubMed - indexed for MEDLINE]
11.

Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study.

Boomsma JM, van Dussen L, Wiersma MG, Groener JE, Aerts JM, Maas M, Hollak CE.

Blood Cells Mol Dis. 2010 Mar 15;44(3):181-7. doi: 10.1016/j.bcmd.2009.12.006. Epub 2010 Jan 13.

PMID:
20074983
[PubMed - indexed for MEDLINE]
12.

Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease.

Weinreb N, Barranger J, Packman S, Prakash-Cheng A, Rosenbloom B, Sims K, Angell J, Skrinar A, Pastores GM.

Clin Genet. 2007 Jun;71(6):576-88.

PMID:
17539908
[PubMed - indexed for MEDLINE]
13.

[Prenatal diagnosis of Gaucher disease].

Germain DP, Benistan K.

Rev Med Interne. 2007 Oct;28 Suppl 2:S193-7. French.

PMID:
18240370
[PubMed - indexed for MEDLINE]
14.

Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat.

Mikosch P, Reed M, Baker R, Holloway B, Berger L, Mehta AB, Hughes DA.

Calcif Tissue Int. 2008 Jul;83(1):43-54. doi: 10.1007/s00223-008-9143-4. Epub 2008 Jun 14.

PMID:
18553043
[PubMed - indexed for MEDLINE]
15.

[Therapeutic objectives in Gaucher disease].

Mistry P, Germain DP.

Rev Med Interne. 2007 Oct;28 Suppl 2:S171-5. Review. French.

PMID:
18228683
[PubMed - indexed for MEDLINE]
16.

The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.

Charrow J, Dulisse B, Grabowski GA, Weinreb NJ.

Clin Genet. 2007 Mar;71(3):205-11.

PMID:
17309642
[PubMed - indexed for MEDLINE]
17.

Clinical and genetic study of Japanese patients with type 3 Gaucher disease.

Tajima A, Yokoi T, Ariga M, Ito T, Kaneshiro E, Eto Y, Ida H.

Mol Genet Metab. 2009 Aug;97(4):272-7. doi: 10.1016/j.ymgme.2009.05.001. Epub 2009 May 10.

PMID:
19481486
[PubMed - indexed for MEDLINE]
18.

Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.

Drelichman G, Ponce E, Basack N, Freigeiro D, Aversa L, Graciela E, Kohan R.

J Pediatr. 2007 Aug;151(2):197-201. Epub 2007 Jun 22.

PMID:
17643778
[PubMed - indexed for MEDLINE]
19.

[Gaucher disease: importance of early diagnosis and therapy].

Simon G, Erdos M, Maródi L, Tóth J.

Orv Hetil. 2008 Apr 20;149(16):743-50. doi: 10.1556/OH.2008.28337. Review. Hungarian.

PMID:
18426721
[PubMed - indexed for MEDLINE]
20.

Goal-oriented therapy with miglustat in Gaucher disease.

Pastores GM, Giraldo P, Chérin P, Mehta A.

Curr Med Res Opin. 2009 Jan;25(1):23-37. doi: 10.1185/03007990802576518 . Review.

PMID:
19210136
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk